ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
The Lancet Neurology
◽
10.1016/s1474-4422(08)70065-6
◽
2008
◽
Vol 7
(5)
◽
pp. 400-408
◽
Cited By ~ 367
Author(s):
William J Marks
◽
Jill L Ostrem
◽
Leonard Verhagen
◽
Philip A Starr
◽
Paul S Larson
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Idiopathic Parkinson’S Disease
◽
Open Label
◽
Adeno Associated Virus
◽
Idiopathic Parkinson's Disease
◽
Virus Serotype
◽
Open Label Phase
Download Full-text
Related Documents
Cited By
References
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
The Lancet
◽
10.1016/s0140-6736(07)60982-9
◽
2007
◽
Vol 369
(9579)
◽
pp. 2097-2105
◽
Cited By ~ 696
Author(s):
Michael G Kaplitt
◽
Andrew Feigin
◽
Chengke Tang
◽
Helen L Fitzsimons
◽
Paul Mattis
◽
...
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Open Label
◽
Adeno Associated Virus
◽
Open Label Phase
Download Full-text
Faculty Opinions recommendation of Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1087568.540634
◽
2007
◽
Author(s):
Robert Sapolsky
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Open Label
◽
Adeno Associated Virus
◽
Open Label Phase
Download Full-text
Faculty Opinions recommendation of Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1087568.543850
◽
2007
◽
Author(s):
Nanna Finnerup
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Open Label
◽
Adeno Associated Virus
◽
Open Label Phase
Download Full-text
429. Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease: Results from an Open-Label, Phase I Trial
Molecular Therapy
◽
10.1016/s1525-0016(16)38787-1
◽
2009
◽
Vol 17
◽
pp. S168
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Amino Acid
◽
Phase I
◽
Phase I Trial
◽
Acid Decarboxylase
◽
Open Label
◽
Amino Acid Decarboxylase
◽
Open Label Phase
Download Full-text
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study
Parkinsonism & Related Disorders
◽
10.1016/j.parkreldis.2012.01.008
◽
2012
◽
Vol 18
(5)
◽
pp. 488-493
◽
Cited By ~ 37
Author(s):
Lawrence W. Elmer
◽
Erwin Surmann
◽
Babak Boroojerdi
◽
Joseph Jankovic
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Early Stage
◽
Extension Study
◽
Idiopathic Parkinson’S Disease
◽
Open Label
◽
Idiopathic Parkinson's Disease
◽
Open Label Extension
◽
Rotigotine Transdermal System
Download Full-text
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study
Journal of Neural Transmission
◽
10.1007/s00702-006-0490-x
◽
2006
◽
Vol 113
(12)
◽
pp. 1909-1913
◽
Cited By ~ 24
Author(s):
A. Romigi
◽
P. Stanzione
◽
M. G. Marciani
◽
F. Izzi
◽
F. Placidi
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Idiopathic Parkinson’S Disease
◽
Open Label
◽
Levodopa Treatment
◽
Idiopathic Parkinson's Disease
Download Full-text
An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease
Journal of Neural Transmission
◽
10.1007/s007020070020
◽
2000
◽
Vol 107
(11)
◽
pp. 1307-1323
◽
Cited By ~ 9
Author(s):
M. M. Pinter
◽
A. W. F. Rutgers
◽
E. Hebenstreit
Keyword(s):
Parkinson’S Disease
◽
Clinical Trial
◽
Parkinson's Disease
◽
Idiopathic Parkinson’S Disease
◽
Open Label
◽
Levodopa Dose
◽
Multicentre Clinical Trial
◽
Idiopathic Parkinson's Disease
◽
Dose Sparing
Download Full-text
Determinants of autonomic dysfunction in idiopathic Parkinson's disease
Aktuelle Neurologie
◽
10.1055/s-2007-987645
◽
2007
◽
Vol 34
(S 2)
◽
Author(s):
A Korchounov
◽
K Kessler
◽
I Reuter
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Autonomic Dysfunction
◽
Idiopathic Parkinson’S Disease
◽
Idiopathic Parkinson's Disease
Download Full-text
Neuronal spiking in the pedunculopontine nucleus in idiopathic Parkinson’s disease and in progressive supranuclear palsy
10.26226/morressier.5b31ec5e2afeeb001345b260
◽
2018
◽
Author(s):
Catherine Sweeney-Reed
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Progressive Supranuclear Palsy
◽
Pedunculopontine Nucleus
◽
Idiopathic Parkinson’S Disease
◽
Idiopathic Parkinson's Disease
Download Full-text
Double jeopardy of multiple sclerosis and idiopathic Parkinson's disease: three new case reports
10.26226/morressier.5b719e455aff74008ae4ccc3
◽
2018
◽
Author(s):
Alexander Scarborough
◽
Yuan Kai Lee
Keyword(s):
Multiple Sclerosis
◽
Parkinson’S Disease
◽
Parkinson's Disease
◽
Case Reports
◽
Idiopathic Parkinson’S Disease
◽
Double Jeopardy
◽
Idiopathic Parkinson's Disease
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close